Representing the complexity of disease with the power to decode it

The Euretos Disease Atlas

Navigate detailed anatomical maps covering 110 organs, 2,500 tissues, and 3,500 cell types for 30,000 diseases and phenotypes - powered by curated, FAIR data and literature

Build deep pathophysiological disease insights – fast

Uncover disease mechanisms, targets, biomarkers, and drug interactions within full anatomical and molecular context—independently and without bioinformatics support.

Build deep pathophysiological disease insights – fast

Uncover disease mechanisms, targets, biomarkers, and drug interactions within full anatomical and molecular context—independently and without bioinformatics support.
Contact Us

Decode Disease Complexity

Use the Disease Atlas to run advanced analyses and uncover disease-specific insights at the relevant anatomical level—with full access to the supporting evidence

Navigate full anatomical maps

Navigate detailed anatimical maps for 30,000 diseases and phenotypes

Identify disease-implicated cell types

Discover the cell types most implicated in disease through their gene associations

Understand cell type prominence

Learn which cell type-expressed genes have disease references, annotations, dysregulation and variants 

Don’t just find your target, understand it

Just search for a target to get a uniquely comprehensive target dossier providing full pathophysiological insight into your target’s location, biological role, and therapeutic potential

Anatomical Expression

Explore target activity through differential expression and disease-linked dysregulation across expression in organs, tissues and cell type

Biological Function

Understand target function in pathways, regulatory networks, and cellular functions in the context of cell–cell interactions, co-expression, and transcriptional control.

Therapeutic Relevance

Assess target efficacy and safety through disease-related phenotypes, genetic variants, and clinical associations together with drug mechanisms of action

Powered by curated, FAIR Data

The Disease Atlas is powered by one of the world's largest collections of literature, patents, experimental, clinical & real-world patient data integrated into a vast, FAIR biological knowledge graph

Empowering translational researchers

The Euretos Disease Atlas empowers translational researchers to take a pathophysiological approach to disease biology—without requiring bioinformatics skills or data science expertise

Unique disease insight through cellular, tissue, and molecular context
Advanced analysis tools with no coding or bioinformatics expertise required
Drastically reduce time spent searching through data, studies, and literature
Interpret results in relation to disease mechanisms and biological relevance

Proven Real-World Results

We have one of the strongest track records in data-driven translational research as our platform and services have contributed to approved drugs and active clinical trials in oncology, Sjogren's disease, Ulcerative Colitis, NASH and epilepsy with 5 different biopharma clients
SVG Graphic

 
tevalogo
"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva."
 
Dr. Dana Bar-On - Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva  Pharmaceuticals. 
 

Understand disease mechanisms across biological levels

Investigate how molecular, cellular, and anatomical factors contribute to disease processes, helping you generate and refine hypotheses grounded in biological context
SVG Graphic

Understand disease mechanisms across biological levels

Investigate how molecular, cellular, and anatomical factors contribute to disease processes, helping you generate and refine hypotheses grounded in biological context
SVG illustration
Get Started
SVG Graphic

Identify and prioritize novel therapeutic targets

Discover targets with strong biological relevance by evaluating expression patterns, pathway roles, and interactions within disease-specific tissues and cell types

Identify and prioritize novel therapeutic targets

Discover targets with strong biological relevance by evaluating expression patterns, pathway roles, and interactions within disease-specific tissues and cell types
SVG Graphic
Contact Us

Evaluate target relevance and actionability

Review key features of candidate targets—such as dysregulation, druggability, and clinical associations—directly in the context of disease biology
SVG Graphic

Evaluate target relevance and actionability

Review key features of candidate targets—such as dysregulation, druggability, and clinical associations—directly in the context of disease biology
SVG illustration
Get Started
SVG Graphic

Rapid access to structured, referenced insights

Find well-organized, publication-backed content on genes, diseases, mechanisms, and treatments to support clear and reliable scientific communication

Rapid access to structured, referenced insights

Find well-organized, publication-backed content on genes, diseases, mechanisms, and treatments to support clear and reliable scientific communication
SVG Graphic
Contact Us
Client review

Target Discovery

"We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general queries."

Tau Benned-Jensen
Senior Research Scientist, H. Lundbeck A/S
Client review

Indication selection

“In this project, we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data-driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.”

Large European Pharma
Global Head
Client review

Target Assessment

"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva."

Dr. Dana Bar-On
Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva Pharmaceuticals
Client review

Target Discovery

"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI platform is a mandatory input to our target discovery meetings."

Large European Biotech
Director Target Discovery
Client review

Indication Selection

"We find that the Euretos group was very easy to work and communicate with. The professional staff at Euretos did a great job extending their platform and capabilities to our advantage. Euretos helped us to extract meaningful information from a highly complex data domain, that we could build on internally."

Henriette Husum Bak-Jensen
Project Manager, Projects & Portfolio department, H. Lundbeck A/S
Client review

Target Assessment

"We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also, the team is well engaged, and had a very good understanding in the background of the project and our research question"

Large Japanese Pharma
Principal Scientist

Data-driven disease insights